Mednovo Group, a diversified large group covers R&D, production, sales, investment and financing, focusing on the medical and health industry.

In Nov. 2020, the headquarter of Mednovo Group was officially settled in the high-tech zone of Suzhou. By establishing various innovative medical device projects in the “self-research + acquisition + equity” model, the company has laid out diversified racing tracks, and achieved the initial construction of a R & D, production and operation system of internationally advanced level, thereby forming a great picture of the industrial technology strategy of the group.

Basing on sales, with strategies as the pulling power, relying on the financial strength,science and technology innovation as the breakthrough point, the future Mednovo Group will carry out R & D of innovative products with independent intellectual property rights, high technology and high quality. Taking root in China and facing the world, the company relies on continuous R & D investment and advanced products to expand market, and strives for becoming the world’s leading high-tech medical solution provider in the field of mini-invasive intervention.